Aetna is the third major payer to change its preauthorization policy for opioid addiction treatment — Bloomfield, Conn.-based Cigna changed its policies in October 2016 and Indianapolis-based Anthem updated its policies last month.
Under the change, physicians will no longer be required to receive approval from Aetna to prescribe medications like Suboxone to treat opioid addiction.
The American Medical Association commended Aetna’s proposed policy change. Patrice Harris, MD, chair of the AMA board of trustees and chair of the AMA Task Force to Reduce Opioid Abuse, said “[p]atient lives will be saved by Aetna’s decision to remove prior authorization for treatment of substance use disorders.”
More articles on opioids:
Addiction treatment boosted under ACA: 5 things to know
Op-ed: How pharma could globalize the opioid epidemic
Former homeland security secretary calls on USPS to better screen packages for illegal opioids
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
